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ABSTRACT Insulin, a small hormone protein comprising 51 residues in two disulﬁde-linked polypeptide chains, adopts
a predominantly a-helical conformation in its native state. It readily undergoes protein misfolding and aggregates into amyloid
ﬁbrils under a variety of conditions. Insulin is a unique model system in which to study protein ﬁbrillization, since its three disulﬁde
bridges are retained in the ﬁbrillar state and thus limit the conformational space available to the polypeptide chains during mis-
folding and ﬁbrillization. Taking into account this unique conformational restriction, we modeled possible monomeric subunits of
the insulin amyloid ﬁbrils using b-solenoid folds, namely, the b-helix and b-roll. Both models agreed with currently available
biophysical data. We performed molecular dynamics simulations, which allowed some limited insights into the relative structural
stability, suggesting that the b-roll subunit model may be more stable than the b-helix subunit model. We also constructed b-sole-
noid-based insulin ﬁbril models and conducted ﬁber diffraction simulation to identify plausible ﬁbril architectures of insulin
amyloid. A comparison of simulated ﬁber diffraction patterns of the ﬁbril models to the experimental insulin x-ray ﬁber diffraction
data suggests that the model ﬁbers composed of six twisted b-roll protoﬁlaments provide the most reasonable ﬁt to available
experimental diffraction patterns and previous biophysical studies.INTRODUCTION
Protein misfolding under conditions that destabilize the
native state, and subsequent fibrillar aggregation of the aber-
rant conformers, are involved in the pathogenic processes of
many neurodegenerative and systemic diseases, such as
Alzheimer’s, the prion diseases, and type II diabetes (1,2).
Misfolded fibrillar proteins share common structural charac-
teristics even when the native proteins are evolutionarily or
structurally unrelated. This observation suggests that the
tendency of misfolded proteins to form ordered aggregates,
known as amyloid, is a generic property of polypeptide
chains (3). Amyloid fibrils are generally unbranched,
protease-resistant filaments with dominant b-sheet structures
organized in a cross-b fashion, in which the b-strands run
perpendicular to the fibril axis (3–5). Electron microscopy
(EM), cryo-EM, and atomic force microscopy (AFM) have
revealed that the protofilament units are compact b-strand
repeats with diameters typically ranging from 15 to 40 A˚
(5–7). Although amyloid fibrils share common structural
properties, their overall morphology can vary depending
on the precursor protein, conditions of fibrillization, and
the number and arrangement of protofilaments (5,7–9).
Over the last few decades, a great deal of effort has been
invested in trying to gain a structural understanding of the
mechanisms of protein misfolding and subsequent amyloid
fibril formation. For example, recent x-ray crystallography
studies of microcrystals formed from short peptides of
amyloid-related proteins have revealed a distinctive packing
in the b-structure core (10,11). EM and solid-state NMR
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that the misfolded amyloid conformation may adopt an
architecture that is structurally unrelated to the native confor-
mation, but similar to b-structures previously observed in
nature, namely b-solenoid folds (12–17). The limitations of
traditional biophysical methods for studying misfolded
proteins have led to the use of molecular modeling to probe
plausible structural solutions. Recently, an investigation of
the amyloid structure of the mammalian prion protein was re-
ported in which experimental fiber diffraction data was
compared to molecular models of prion amyloid (18).
Insulin, a small hormone protein consisting of two poly-
peptide chains, adopts an a-helical conformation in its native
state. The insulin sequence is well conserved among mam-
malian species, with few variations. Two polypeptide chains
are linked by two interchain and one intrachain disulfide
bridges (19). Although insulin does not appear to be directly
involved with any known human amyloid diseases, native
insulin readily converts to an inactive fibrillar form under
a wide range of conditions (19). In one clinical study,
amyloid-fibril-like deposits containing insulin were found
at sites of insulin injection in a diabetic patient (20). An inter-
esting feature of insulin is that its three disulfide bridges are
retained in the in vitro and ex vivo fibrillar form (5,19,21).
Thus, these disulfide bonds must constrain the possible
conformational rearrangements during the a-helix-to-b-sheet
transition (21). This conformational constraint makes insulin
a unique model system for studying protein misfolding and
subsequent amyloid fibrillization.
Native insulin often exists as a zinc-coordinated trimer of
dimers under physiological conditions or, alternatively, as
a dimer or tetramer in a zinc-free environment (19,21,22).
Under conditions of low pH and high temperature, insulin
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bles into fibrils or aggregates (5,19). Insulin fibril formation
was first observed in the 1940s, and the nucleation and elon-
gation process was first reported by Waugh (23). In 1972, a
fiber diffraction study by Burke et al. showed the cross-b
structural pattern of insulin (24). Studies using NMR have
demonstrated that the native insulin structure is disrupted
before fibrillization occurs (25). Recent mass spectrometry,
AFM, hydrogen exchange, and small-angle x-ray scattering
(SAXS) studies have shown the formation of small oligo-
meric species consisting of up to 12 insulin molecules. These
species act as elongating units that further assemble into
larger irreversible aggregates and ultimately into protofila-
ments and mature fibrils (26–29). Studies using Fourier
transform infrared (FTIR) and circular dichroism (CD) spec-
troscopy indicate that the initial aggregates retain their
predominantly a-helical structure, but that there is a subse-
quent conversion to a b-sheet structure as the fibrillization
process continues (9).
In this study, we modeled a b-rich insulin monomer using
either a b-roll or b-helix fold as templates, and assessed the
suitability of each of these models as possible subunits of
fibrillar insulin. We examined each model based on available
biophysical data, and studied the relative stability of the
model structures using molecular dynamics (MD) simula-
tions. Fibrillar insulin models were constructed using each
of the monomer models, and fiber diffraction patterns were
simulated. By comparing the simulated fiber diffraction
patterns with those obtained experimentally from insulin
fibers, we were able to assess the suitability of each model.
MATERIALS AND METHODS
Molecular modeling of the insulin monomer
The b-roll and b-helix models of C-terminally truncated human insulin
(A chain, 1–21; and B chain, 1–22) were built using the iron transporter
stabilizer protein SufD (Protein Data Bank (PDB) ID code 1VH4) and the
C-terminal domain of N-acetyglucosamine 1-phosphate uridyltransferase
GlmU (PDB ID code 1HV9) as templates. For the b-roll model, the struc-
tural coordinates from residues 254–274 and 230–249 of 1VH4 were copied
and reassembled onto the scaffold so as to follow the selected threading of
the insulin A and B chains, respectively (see Results). For the b-helix model,
the coordinates from residues 309–323 and 293–312 of 1HV9 were used to
build the A and B chains, respectively. b-roll and b-helix polymeric models
were constructed by stacking four repeated subunits on top of each other
with an intermolecular distance between two neighboring subunits of
4.8 A˚. (For details, see Methods in the Supporting Material).
Molecular dynamics simulation of monomeric
insulin models
All simulations were performed with the GROMACS software package
(30), using the GROMMOS 43a3 force field (31), as described in previous
studies (32,33). The model structures used in the simulations were the
C-terminally truncated b-roll and b-helix insulin. Models were solvated indi-
vidually in octahedron boxes filled with water molecules. Sodium ions were
used to electroneutralize the system. Solutes, solvent, and counterions were
coupled independently to reference temperature baths at 300 K, 345 K, andBiophysical Journal 97(12) 3187–3195375 K, and the pressure was maintained by weakly coupling the system to an
external pressure bath at 1 atm. To emulate the acidic, fibrillogenic condition
of pH ~2, two histidine residues, one glutamate residue, and the C-terminus
were protonated. Analysis was performed using the built-in programs of the
GROMACS software package (30). (For details, see Methods in the Sup-
porting Material).
Molecular modeling and ﬁber diffraction
simulations of the insulin ﬁbril
Molecular models of the fibrils were built by translating the b-roll and
b-helix monomeric units along the fibril axis and rotating them around the
axis. The degree of rotation varied depending on the helical period of the
fibril, which is caused by b-sheet twisting. As a result, two or more protofila-
ments were used to form a fibril by winding around each other. All insulin
fibril models were constructed using InsightII (Accelrys, San Diego, CA)
and DISORDER (35), based on structural constraints, such as the helical
period, number of protofilaments in the fibril, and the relative positions
and orientations of the monomers in the fibril cross section (5,26).
The simulation and analysis of fiber diffraction patterns were conducted
using DISORDER (35). For every fibril model, the diffraction patterns,
with varying degrees of disorientation between fibrils, were simulated.
The value of the disorientation parameter varied from 10–25. The meridi-
onal and equatorial profiles of the simulated and experimental fiber diffrac-
tion patterns were then compared by calculating the least-squares residuals
(35). Simulated and experimental diffraction patterns were visualized using
FIT2D (36). (For details, see Methods in the Supporting Material).
RESULTS
Molecular modeling of the monomeric subunit
of the insulin ﬁbril
In modeling the insulin monomeric subunit, we threaded
(37) the insulin sequence onto the known b-solenoid folds,
namely the parallel b-roll and b-helix, found in the PDB
database (Fig. 1 and Fig. S1 in the Supporting Material).
In general, b-rolls contain two b-strands per rung with
four-residue turns (arcs), which allow the strands to change
direction by 180, whereas the b-helices are composed of
three b-strands per rung with three-residue turns (arcs) and
a turn angle of ~120 (15,38). As mentioned above, one of
the unique features of insulin is its three disulfide bridges
within chains A and B, all of which are retained in the
fibrillar state (19,21). Previous mutagenesis and deletion
experiments have shown that the C-terminal region of chain
B (residues 23–30) is not required for insulin fibrillization
(19,39). With these structural constraints in mind, the thread-
ing of insulin chains A and B onto a b-roll or b-helix
produced relatively simple and unique solutions. Few thread-
ing solutions could satisfy the disulfide bridge constraints,
structural features of the b-solenoid folds, and the available
experimental data, including experiments using insulin
single-chain analogs and isomers, fibrillization of isolated
chains A and B, and biophysical characterization of insulin
fibers using cryo-EM, CD, and FTIR (5,9,15,21,33,40–42).
In the b-roll model, insulin was threaded into two rungs,
with each rung comprising one short and one long b-strand
connected by tight turns and a disulfide bridge. In the b-helix
model, the insulin sequence was also threaded into two rungs
Modeling of Insulin Amyloid Fibril 3189FIGURE 1 Insulin monomer structure and b-solenoid-
based monomeric subunit models for the insulin amyloid
fibril. (A) Insulin monomer structure (PDB code 1GUJ),
with the sequences of chains A and B. One intrachain
and two interchain disulfide bridges are shown in yellow
in the structure and by connecting lines in the sequences.
The C-terminal region of chain B, underlined and in italic,
is not involved in amyloid fibrillization. Multiple sequence
alignment of the insulin sequences from five different
mammalian species is shown, with sequence variations in
the boxes. (B and C) Cross-sectional views of insulin
b-solenoid monomeric models, including the C-terminally
truncated b-helix (B) and b-roll (C) insulin monomeric
subunit models, based on templates from 1HV9 (segment
293–323) and 1VH4 (segment 230–274), respectively.
Stick figures are shown with the side chains, with disulfide
bridges in yellow. Schematic figures are shown with the
amino acid residues facing inside, with approximate
dimensions of the structures. Chains A and B are shown
in blue and red, respectively.of a b-helix with three short b-strands per rung, forming
a triangular shape with an opening at one corner. Although
chain B of the b-helix model contains typical b-helical turns
as observed in nature, chain A contains an unusual four-
residue turn with a disulfide bridge, connecting the adjacent
b-sheets. Although the types of disulfide bridges introduced
into the b-solenoid models are not commonly found in
b-solenoid proteins, they are structurally feasible. However,
introducing disulfide bridges at the turn regions of the insulin
b-helix model resulted in slight distortions to the b-sheets.
Both insulin models satisfied the sequence and structural
features of the b-roll and b-helix folds, such that residues
facing the inner core of the structures were mostly similar
hydrophobic or small polar residues that stacked on top of
each other (15,33,38). In particular, the inner-core residues
of the b-helix model were well packed, with similar residues
stacking in two chains. The inner-core packing of the b-roll
model was less consistent than that of the b-helix model,
with glutamine and glutamate residues residing in the core;
however, these residues are occasionally found in native
b-roll proteins. In addition to structural constraints, the
b-solenoid insulin models may also explain the exclusion
of the C-terminal region of the B chain from the fibrils. In
both models, the C-terminal region (B chain, residues
23–30) did not fit onto the b-solenoid structures due to
side-chain constraints. It therefore made logical sense to
place this stretch of sequence outside of the b-solenoid core.
The b-solenoid models of the insulin fibrillar subunit also
agreed well with studies characterizing the fibrillization of
insulin disulfide isomers and isolated chains A and B, and
single-chain analogs (21,41,42). For example, insulin struc-
tural isomers with alternative pairings of disulfide bridges,
which were shown to form amyloid fibrils, were compatible
with both the b-roll and b-helix models. These disulfide
isomers retained the A20-B19 pairing, whereas the A6-A11
and A7-B7 pairings were alternated with one another.Although these alternative disulfide pairings are not ideally
suited to the insulin b-solenoid models shown in Fig. 1,
they can be tolerated by using different registers at the turn
regions of both models. The cross-seeding experiments using
native and isomeric insulin (42) also agreed with compati-
bility of both the native and isomeric insulin with the b-sole-
noid models. Furthermore, the b-solenoid models agree with
isolated single chain insulin fibrillization experiments. One
rung of the b-solenoid structure formed by the isolated single
chain of either chain A or chain B can further aggregate
into homogeneous protofilaments, with morphologies and
dimensions different from those of the wild-type insulin
fibrils but retaining the ability to cross-seed with wild-type
insulin (21,40,41). Conversely, a single-chain analog in
which the C-terminus of chain B was tethered to the
N-terminus of chain A was shown to lack fiber-specific
a-to-b transition. This can be explained also by the inability
of the single-chain analog to adopt a b-solenoid conforma-
tion, as such an insulin sequence is not compatible with
the sequence and structural requirements of the fold.
A previous cryo-EM study showed that protofibrillar
insulin was composed of relatively flat b-sheets with typical
sizes ranging from 30–40 A˚ in diameter (5). Although the
b-helix model was relatively symmetrical, with dimensions
of 20–30 A˚  30–40 A˚, the b-roll model had a long rectan-
gular shape with a width of 15–25 A˚ and a length of 35–45 A˚
(Fig. 1, B and C). Although the C-terminal region of chain B
is not shown in the figures and was not used to calculate the
dimensions, the size estimates of both models were in fair
agreement with the approximate dimensions of the insulin
protofilament calculated from the cryo-EM experiments. In
addition, the b-solenoid structures of insulin fibrillar subunit
models can provide the characteristic cross-b pattern and
b-signatures, which were consistently observed in fiber
diffraction, FTIR, and CD studies of insulin and other
fibrillar protein aggregates (9,26,43).Biophysical Journal 97(12) 3187–3195
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ﬁbrillar insulin subunits
We conducted 40-ns MD simulations using the b-roll and
b-helical insulin monomers with intact disulfide bridges
under acidic conditions, using a range of temperatures
(300–375 K) to emulate the experimental conditions of
in vitro insulin fibrillization (see Materials and Methods).
Analysis of the positional root mean-square deviations
(RMSDs) of the backbone relative to the starting structures
indicated that each model reached equilibrium after ~13 ns.
The relative stabilities of the model structures estimated by
RMSD revealed much larger differences among the insulin
b-helix models than among the b-roll models at the three
different temperatures (Fig. 2). The b-helix models showed
an increase in RMSD of ~2 A˚ when the temperature was
increased by 30–45 K. The average RMSDs for Ca, and
the interchain backbone-backbone hydrogen bonds, were
calculated from three independent trials for both b-solenoid
models (Table S1). Although little difference was seen
between the b-roll and b-helix models from the interchain
hydrogen bonds before and after a 40-ns simulation, the
FIGURE 2 Molecular dynamics simulation of the b-roll and b-helix
insulin monomeric models with increasing temperature in acidic conditions.
Backbone RMSDs of the b-roll (A) and b-helix (B) models relative to their
initial structures (upper left corner) as a function of simulation time at
300 K, 345 K, and 375 K. Final structures are shown at the right in order
of increasing temperature (lower to upper).Biophysical Journal 97(12) 3187–3195average RMSDs of Ca of the two models consistently
showed significantly different stability. This result provides
limited evidence that the b-roll model may be relatively
more stable than the b-helix model at increased tempera-
tures. For each model, the final structures after a 40-ns MD
simulation also revealed that although the b-roll models
maintained their initial fold architecture relatively well, the
b-helix model displayed an early-stage disruption of the
b-helical fold at 345 K and a structural transition to
a pseudo-b-roll-like structure at 375 K with two strands
per rung with four-residue turns allowing the strands to
change direction by ~180 (Fig. 2 B). We also conducted
100-ns MD simulations of b-roll and b-helix monomer
models at 375 K to investigate the structural conversion
between these two structures. However, there was no defin-
itive evidence from this particular experiment to suggest that
a structural conversion between these two conformations
could occur (data not shown).
The relative stability of polymeric constructs comprising
four repeated units from either the b-roll or b-helix insulin
model was also explored usingMD simulations to investigate
the stability of the b-solenoid insulin oligomers and of the
b-solenoid insulin monomers in the oligomeric state. The
conformational stability of b-helical polymeric constructs
was previously examined to assess their ability to retain their
organization and self-assembly status (44,45). We conducted
MD simulations at 345 K in acidic conditions for 15 ns. The
relative stabilities of the b-roll and b-helix polymeric models
were compared using the RMSD of Ca calculated relative to
the starting models, and the monomeric subunits located in
the middle of polymeric models (second and third subunits)
were compared to the initial structures (Fig. S2, A and B).
Although theMDsimulation of the polymericmodels showed
improved structural stability relative to the stability of mono-
meric models in the monomer simulations, the b-roll poly-
meric model still showed a slightly higher stability than the
b-helix polymeric model. The final structures of the second
units within the polymeric constructs were closely examined
to understand the changes in backbone angle and side-chain
packing after 15 ns of MD simulation (Fig. S2 C). Unlike in
the single-unit simulation, the hydrophobic cores of these
subunits were not exposed to the solvent. In the case of the
b-roll subunit, the side-chain packing was relatively well
maintained after 15 ns simulation. Most of the structural devi-
ation originated from movements of the C-terminal region of
chain B. In contrast, the final structure of the b-helix subunit
showed a large degree of structural deviation at the turn region
where the two disulfide bonds reside, and this deviation
resulted in movements of the backbone and the overall struc-
ture of the polymeric construct.
Molecular models of insulin ﬁbrils
We modeled the insulin fibril using both the b-roll and
b-helix insulin subunit models as building blocks. Two types
Modeling of Insulin Amyloid Fibril 3191FIGURE 3 Quaternary structure arrangements to simu-
late insulin amyloid fibrils. (A) Cross-sectional view of
the b-roll-based insulin fibril models with two (a–c), four
(d), and six (e) protofilaments. (B) b-helix-based models
with two (a and b), four (c), and six (d) protofilaments.
Fibril models were constructed based on the measured
layer line spacings calculated from the diffraction patterns
of insulin amyloid fibrils (8). (C) Trimeric (a), tetrameric
(b), pentameric (c), hexameric (d), and octameric (e)
models of a b-helix-based protofilament. Models were con-
structed based on helical periodicity calculated from the
insulin oligomeric species observed by SAXS (26).of fibrillar molecular models were explored: 1), a twisted-
stack arrangement (Fig. 3, A and B); and 2), a helical archi-
tecture (Fig. 3 C), based on the previous cryo-EM and SAXS
data, respectively. Twenty-three different insulin fibril
models were constructed with three different architectural
schemes. Of these fibril models, 14 are shown in Fig. 3.
According to a previous cryo-EM study, two to six proto-
filaments can be intertwined to make a larger fibril with
approximate dimensions of 30  40 A˚ for a single protofila-
ment (5). Since the diameters of the b-solenoid models
ranged from ~20–40 A˚, the parallel stacking of monomer
subunits along the fibril axis fits the cross-sectional area of
a single protofilament. To construct twisted-stack fibril
models comprised of two, four, and six protofilaments, the
b-solenoid subunits were moved and rotated within the
120 A˚  150 A˚  10 A˚ lattice (5). Lattice dimensions were
based on the approximate dimensions of the six-protofila-
ment fibril cross section. The final fibril models were then
constructed by translating these repeating units along the
axis of the fibril with helical periods of ~525 A˚, 355 A˚,
and 426 A˚. Helical periods were taken from the previously
reported layer line spacing values of two-, four-, and six-pro-
tofilament fibrils (5). The final fibril models were distorted
crystallite structures that had a long-range twist, with a corre-
sponding helical period.
A previous modeling study based on SAXS data sug-
gested that the helical oligomeric species intertwine into
a dense protofilament, and that the two protofilaments twist
around each other to form a protofibril (26). Based on the
estimated dimensions of insulin oligomeric species observed
by SAXS and the tentative model of the insulin fibril
proposed in these studies, we constructed five helical models
consisting of three, four, five, six, and eight intertwined
b-helices. The b-roll subunit model was similarly examined,
but it failed to provide reasonable solutions for the insulin
fibril (data not shown). In contrast to the proposed model
by Vestergaard et al. (26), which has eightfold symmetry
formed by eight helical oligomers intertwined to form a pro-tofilament with an average diameter of ~50 A˚, the b-helix-
based helical models have diameters ranging from 50 A˚
for a trimeric model to 85 A˚ for an octameric model. Consid-
ering the dimensions of the insulin protofilament calculated
from cryo-EM data (30–40 A˚), the only sensible model
was the trimeric helical model, in which three b-helix-based
protofilaments intertwined with one another. A pair of
trimeric b-helical protofilaments twisted around each other
to form a protofibril with a diameter of ~100 A˚ was consis-
tent with both the cryo-EM (5) and SAXS studies (26).
The fiber diffraction patterns calculated for b-solenoids
with parallel and antiparallel b-sheets were different. Fiber
structures containing b-solenoids organized in parallel
fashion produced a meridional arc at ~9.6 A˚, whereas those
with b-solenoids organized in antiparallel fashion produced
meridional arcs with a twofold higher periodicity. Since
the experimental insulin x-ray diffraction pattern (26) did
not show a meridional arc at 19 A˚, this allowed us to exclude
antiparallel organization of b-solenoid models from consid-
eration.
Simulated versus experimental ﬁber diffraction
patterns of the insulin ﬁbril
Using the b-solenoid insulin fibril models, we simulated
fiber diffraction patterns for 1), b-roll and b-helix-based
two-, four-, and six-protofilament twisted-stack models;
and 2), b-helix-based helical models. The simulated diffrac-
tion patterns of the fibril models were calculated and
compared with the experimental patterns (Fig. S3, Fig. S4,
and Fig. S5). For comparison, the meridional and equatorial
arc profiles of the simulated diffraction patterns were
compared against those of the experimental diffraction
patterns of the insulin amyloid fibril, and the similarity scores
were calculated using the least-squares method (Table S2
and Table S3).
In the fiber diffraction simulations of the insulin fibril
models, the meridional arc results from the periodic packingBiophysical Journal 97(12) 3187–3195
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lated diffraction patterns of an insulin
amyloid fibril and a six-protofilament
b-roll-based insulin fibril model. (A)
Quadrant view of the experimental
insulin x-ray fiber diffraction pattern
(E) (26) and the simulated fiber diffrac-
tion patterns of a six-protofilament
insulin fibril model using the b-roll
monomeric subunit as a building block,
constructed by DISORDER (S) (48).
The image was prepared by FIT2D
(36). (B) Meridional and equatorial arc
profiles of the experimental and simu-
lated diffraction patterns, with two
meridional arcs, at ~9.6 A˚ and ~4.8 A˚
(M1 and M2, respectively), and three
equatorial arcs, at ~33 A˚, ~15 A˚, and
~10 A˚ (E1–E3, respectively). (C) Tenta-
tive model of the six-protofilament b-roll-based insulin amyloid fibril. The image was prepared by the UCSF Chimera package (48). The experimental x-ray
fiber diffraction pattern of insulin amyloid was collected under the experimental conditions of the SAXS analysis from which the mature fibril consisting of six
intertwining protofilaments was evaluated (26).of the insulin molecules in the direction along the fiber,
whereas the equatorial arc results from periodic b-sheets
stacking in the direction across the fiber.
The meridional region of the insulin experimental diffrac-
tion pattern is dominated by a strong intensity arc at ~4.8 A˚
resolution. This feature corresponds to the distance between
adjacent b-strands and indicates that the strands are oriented
perpendicular to the fiber axis. This 4.8-A˚ meridional signal
extended all the way into the equatorial region due to its
overall strength and to a pronounced disorientation of the
amyloid fibrils. A weak, diffuse meridional arc, observed
at ~9.6 A˚ resolution, is believed to reflect periodic repeats
of identical chains along the fiber. The simulated diffraction
patterns of all the models showed a strong meridional arc at
~4.8 A˚ due to hydrogen-bonded peptide-peptide spacing
between the b-sheets. In contrast, the intensity and range
of the meridional arc at ~9.6 A˚ varied between the models.
The diffraction patterns of all the b-roll fibril models consis-
tently showed a relatively weak single peak at ~9.6 A˚. This
would be expected from fibril models constructed using two-
rung b-solenoid structures as assembling subunits. However,
the b-helix fibril models gave diffraction patterns with
multiple peaks of various intensity at ~9.6 A˚ (Fig. S4).
This may reflect some irregularity and distortion in the
b-sheets caused by introducing disulfide bridges at the turns
of the b-helix subunit model. Although it is difficult to simu-
late the exact location and intensity of the meridional arcs
seen in experimental diffraction patterns, the b-roll fibril
models showed a reasonable fit to the meridional arcs
(Fig. 4 and Fig. S3).
For the equatorial arcs, a wide range of variations ap-
peared in the number, intensity, and location of arcs among
the different fibril models. The experimental diffraction
patterns revealed three major equatorial arcs at ~33 A˚,
~15 A˚, and ~10 A˚, which are believed to reflect the stackingBiophysical Journal 97(12) 3187–3195distances of b-sheets within the chains and between the
subunits along the cross section of the amyloid fibrils
(Fig. 4 B). As described above, the 4.8-A˚ meridional signal
was smeared out to such an extent that the diffraction pattern
showed a weak signal at 4.8 A˚ in the equatorial region. Thus,
this signal was not considered as one of the equatorial arcs.
We focused on identifying fibril models that would generate
comparable arcs at the ~33 A˚, ~15 A˚, and ~10 A˚ regions by
exploring two-, four-, and six-protofilament arrangements of
the b-roll and b-helix models, with different arrangements of
the subunits and variations in the b-sheet stacking distance
(Fig. S3 and Fig. S4). A model fibril composed of six-proto-
filament b-roll model subunits (Fig. 3 A, e) generated the
most comparable triplet of the equatorial arcs (Fig. 4 and
Fig. S8). Other fibril models failed to match this pattern of
equatorial arcs.
We also simulated and searched the fiber diffraction
patterns from the b-helix-based helical models, which were
built based on previous SAXS study data, to explore the
possibility of alternative arrangements of insulin protofila-
ments (Fig. S5). However, none of the simulated diffraction
patterns of these b-helix fibril models resulted in comparable
arcs at the regions discussed above.
DISCUSSION
b-solenoid models satisfy experimental
constraints of misfolded insulin
Insulin is a unique system with which to model amyloid
fibrils, given the conformational restrictions imposed on
the protein by its intrinsic disulfide bridges. These b-solenoid
structures provide the cross-b pattern and b-signatures seen
in fiber diffraction, FTIR, and CD studies of amyloid fibrils.
In addition, previous studies on the fibrillization of insulin
Modeling of Insulin Amyloid Fibril 3193single-chain analogs, disulfide isomers, and isolated single
chains are consistent with our b-solenoid models. Based on
the approximate cross-sectional dimension, both the b-roll
and b-helix models were comparable to the insulin fibril,
but the b-helix model was a slightly better fit to the estimated
diameters of the insulin protofilament.
Although the mechanism of amyloid fibrillization remains
unclear, it has been suggested that some proteins may
undergo a reorganization of their global structures while
retaining native structural elements. Other proteins may
require substantial unfolding and subsequent conversion of
a-helix to b-sheet. In the case of insulin, previous studies
suggested that insulin may retain its three disulfide bridges
during the conformational rearrangements as it undergoes
extensive conversion to b-sheet structure (5). A comparison
of the cross-sectional views of the native and b-solenoid
insulin model structures showed that a structural transition
from the a-helical to the b-solenoid structure may be
possible with the disulfide bridge intact. Thus, b-solenoid
insulin models may provide a possible explanation for the
misfolding and fibrillization events that can occur in a phys-
iological environment.
A multiple-sequence alignment of mammalian insulins
showed that some species contain point mutations, such as
histidine at A18 for feline and proline at B9 for rat insulin,
which may prevent folding to a b-helical structure as they
allow folding to a b-roll structure. These two mutations are
located in the hydrophobic core of the b-helix model, which
cannot accommodate histidine or proline. The same muta-
tions can be tolerated in the b-roll model (Fig. 1). Follow-
up experiments on the fibril-forming tendency of insulins
from these species or cross-seeding studies with human
insulin may provide additional information as to whether
the b-roll or b-helix fold is the better modeling solution.
Structural stability of the insulin b-solenoid
monomer models
Although research as to whether oligomeric species or
mature amyloid fibrils act as toxic agents in the pathogenic
process is ongoing, increasing evidence indicates that the
monomeric units of misfolded amyloid proteins may act as
templating or assembling units for the larger intermediate
aggregate species (26,46,47). Some key features of b-roll
and b-helix folds that make them good candidates as mono-
meric structural units of the insulin fibril are the inherent
compactness of their folds and the availability of accessible
b-faces to initiate and sustain self-assembly. Previous studies
of the b-helices have shown that the two-rung unit of the
b-helical fold is likely to be the minimal stable unit, and
that the packing of the hydrophobic core is the essential
determinant of global stability (33). In addition, we have
previously shown that native disulfide bridges may help in
the stabilization or folding of the b-helix fold (33). Molecular
models of b-solenoid insulin indicate that this protein canadopt two full rungs of b-rolls or b-helix folds and accom-
modate well-packed side chains in its core. However, it is
difficult to evaluate the absolute thermodynamic stability
of the monomeric unit to evaluate its possible role in the
nucleation and elongation steps of amyloid fibrillization.
Molecular dynamics simulations can be used to evaluate
the relative stability of different insulin monomeric and poly-
meric models compared to their initial structure under fibril-
logenic conditions. Although the actual protein stability may
deviate from this relative stability estimation, such simula-
tions may provide some limited insight into how similar
models of the same protein would behave under the same
fibrillogenic conditions. Based on our simulation of two
different b-solenoid insulin models at different temperatures,
the b-roll model may be the more stable structure. Although
it is difficult to extrapolate these findings to fiber stability, it
seems reasonable to speculate that this predicted increase in
stability might have an impact on amyloid fiber propagation.
Molecular models of the insulin ﬁbril
and a comparison of simulated and experimental
ﬁber diffraction patterns
Although x-ray fiber diffraction studies can provide the char-
acteristic cross-b pattern structure that is a signature of
amyloid fibrils, this technique alone has not been very effec-
tive in determining the detailed structural arrangement of
amyloid fibrils, despite recent improvements in high-resolu-
tion fiber diffraction. Diffraction images can provide gross
structural information, subject to the quality of the fiber
under study. For example, subtle variations in the diffraction
image often result from differences between sample prepara-
tions. One approach to harnessing the information contained
within diffraction images is to start with fibril models and
generate theoretical fiber diffraction patterns through com-
puter simulation and compare these patterns to an experi-
mental pattern to validate or refute the models (18). In this
way, the most likely fibril structure can be identified from
many thousands of possible structural solutions. Although
comparing simulated and experimental fiber diffraction
patterns does not provide explanations for experimental
factors that may affect fiber diffraction, it can be useful for
studying the relative difference in diffraction patterns gener-
ated by similar fibrillar structures. In this study, only the
experimental fiber diffraction data up to 4.4 A˚ resolution in
the meridional direction and 6.7 A˚ in the radial direction
were used, as we could not perform a reasonable background
subtraction in the higher-resolution areas. Despite these limi-
tations, and the difficulty of using the entire set of diffraction
data, we were still able to generate reasonable models based
on the dimensions and helical geometry of the fiber, dimen-
sions of the asymmetric unit, and details of the fold, such as
the packing of b-strands in the asymmetric unit. The predic-
tions were made based on ranking of the trial models by
calculating least-squares residuals.Biophysical Journal 97(12) 3187–3195
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number of protofilaments involved (5). In an attempt to
acquire a more detailed understanding of the fibril structure
and its arrangement, we used simple monomeric b-solenoid
models to build complex fibril models by varying the number
of protofilaments and their arrangement. Using a computa-
tional method developed to simulate the diffraction pattern
of disoriented fibrils, we tested whether the diffraction
patterns from the constructed b-solenoid fibril models were
comparable with the experimental patterns. A search for
the best-fitting model through the enumeration of different
models, arrangements, spacings between protofilaments,
and degrees of disorientation resulted in the selection of
a six-protofilament b-roll fibril model. The final fibril model
is consistent with previous studies showing six intertwining
protofilaments or three protofibrils formed by two protofila-
ments each (5,26).
Although the comparison of fiber diffraction patterns
showed that the six-protofilament b-roll insulin fibril model
agreed well with the experimental data, there were two major
discrepancies. First, a model could not be identified that
would generate a meridional arc at ~33 A˚ and also showed
a disoriented meridional signal at ~4.8 A˚ that extended to
the equatorial region (Fig. 4 B). However, we believe that
these peculiar signatures may have been caused by misorien-
tation of the amyloid filaments within the dried fibril which
could not be simulated by the program DISORDER. Second,
therewas a large difference in intensity between the equatorial
arcs. As shown in Fig. 4 A, the experimental diffraction
pattern showed relatively stronger andwider peaks, especially
at ~10 A˚, than did any of our simulated patterns. Although
differences between the actual insulin and the fibril model
are major concerns, these may have resulted from disorienta-
tion of the amyloid fibrils due to heterogeneities arising in the
fibrils. The physical nature of amyloid fibril disorientation is
still poorly understood and therefore difficult to account for
in computational simulations. Also, the flexible C-terminus
of the B chain, whichwas not included in thismodeling study,
may affect the diffraction signal. As an attempt to explore the
possible contribution of conformational heterogeneity within
the fibrils to disorientation of the amyloid fibrils and their
diffraction patterns, we conducted fiber diffraction simula-
tions for six-protofilament, twisted-stack fibril models, based
on the final structures of theb-solenoid insulinmonomer units
from the 40-ns MD simulations, as well as hybrid fibril
models, comprising both b-roll and b-helix monomer units
(Fig. S6 and Fig. S7). Although diffraction patterns built
from the final structures of the MD simulations did not
show any significant improvements, the hybrid fibril models
showed better fits for the meridional and equatorial profiles
(Table S2). Further studies are necessary to probe how confor-
mational heterogeneity can be applied in the search for
a better-fitting fibril model, and to understand the nature of
the disorientation of amyloid fibrils. These efforts will no
doubt include the generation of higher-resolution fiberBiophysical Journal 97(12) 3187–3195diffraction patterns with increasing resolution of the meridi-
onal and equatorial arcs. Even with improved patterns, fiber
diffraction simulations and analysis can only be effective
when the information we gather from molecular models is
reasonably accurate in terms of the dimensions and basic
architecture of the amyloid fibrils. However, despite the
recognized limitations, we are satisfied that method of fiber
diffraction simulation described in this article can be an effec-
tive tool to study fiber structure where techniques that require
higher resolution (e.g., x-ray crystallography) are not appli-
cable.
CONCLUSIONS
Solid-state NMR, fiber diffraction, EM, and AFM studies of
Ab140 and the fungal HET-s prion protein have shed light
on structural properties of amyloid fibrils. Amyloid fibrils
share a structural architecture resembling that of b-solenoid
folds such as b-rolls and b-helices. However, studies
suggest, there is also morphological diversity among the
different amyloid fibrils, which may reflect structural diver-
sity of the monomeric structural unit. To further understand
the detailed structural arrangements of the amyloid fibril, we
used several computational tools to model and investigate
the insulin monomeric subunit and fibril. We have shown
here that the b-solenoid is an architecture likely to be adop-
ted by insulin in the fibrillogenic state, although further
studies are necessary to examine the discrepancies between
our theoretical models and experimental data.
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